Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mar 30, 2010

Premium

Frank Pitzer has been named CEO of Roche NimbleGen, Roche said last week. He replaces Gerd Maass, who led Roche NimbleGen for two years.

Pitzer most recently served as head of divisional quality and regulatory affairs at Roche Diagnostics. He holds a PhD in biology from the Max Planck Institute for Biochemistry.


Michelle Lyles has been named vice president of sales at Hamilton Thorne, the company said last week.

Lyles was most recently vice president of marketing and sales at Febit. Before that, she served as director of US sales at Sigma-Aldrich, and vice president of sales and marketing at Panomics, now Affymetrix.

Lyles holds a PhD in biochemistry from Baylor College of Medicine.


NanoString Technologies has tapped William Young to be executive chairman of its board of directors. Young formerly was CEO and chairman of Monogram Biosciences and he was chief operations officer at Genentech. He currently serves as chairman of the board of directors of Biogen, chairman emeritus for BayBio, and as a director at Theravance.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.